The post Roche launches Axelios 1 sequencing platform appeared first on Hospital Management. The post Roche launches Axelios 1 sequencing...
Axsome Therapeutics has dosed the first patient its FOCUS-3 Phase III clinical trial assessing solriamfetol in adolescents with ADHD.The post...
Lilly has received the CHMP of the EMA positive opinion for Jaypirca (pirtobrutinib) to treat chronic lymphocytic leukaemia (CLL) in...
J&J has begun enrolment in its SKYWARD IDE clinical programme to evaluate the Shockwave SkyRunner Carotid IVL system.The post J&J...
Racura Oncology has dosed the first patient in the Phase Ia/b HARNESS-1 trial assessing a combination of RC220 and osimertinib...
Ionis Pharmaceuticals has granted Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside...
RQ Bio has closed a $115m Series A funding round to advance its long-acting antibody therapeutic programme RQB01, which targets...
Viking Therapeutics has commenced a Phase I clinical trial of VK3019, a DACRA, which is under development as a potential...
Quest Diagnostics has received approval from the NYSDOH CLEP for its Haystack MRD test, expanding its use to cancer patients...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.